Viewing Study NCT02859350


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-21 @ 11:19 PM
Study NCT ID: NCT02859350
Status: COMPLETED
Last Update Posted: 2018-10-15
First Post: 2016-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Sponsor: Sanaria Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EGSPZV2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View
None INDUSTRY View
None UNKNOWN View
None OTHER View
None INDUSTRY View